CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Autoimmune Disease
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06375993
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:11.142392+00:00
- Published At
- 2026-03-19T00:00:00+00:00
- Record Updated At
- 2026-03-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lupus Nephritis", "Autoimmune Diseases", "Systemic Sclerosis (SSc)", "Systemic Lupus Erythematosus (SLE)", "ANCA-Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myopathies", "Stiff Person Syndrome"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-19"- protocolSection.identificationModule.nctId
"NCT06375993"- protocolSection.identificationModule.officialTitle
"A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (\u03b3\u03b4) T Cells in Adults With Autoimmune Disease"- protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.